Immunovant, Inc. (IMVT) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$16,682
Total Return
66.82%
CAGR
10.78%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +2.60% |
| Median | -1.73% |
| Best | +127.43% |
| Worst | -40.05% |
| % of Windows Positive | 45.1% |
1-Year (252 Trading Days)
| Average | +69.86% |
| Median | +25.21% |
| Best | +774.23% |
| Worst | -76.34% |
| % of Windows Positive | 56.9% |
3-Year (756 Trading Days)
| Average | +181.40% |
| Median | +198.36% |
| Best | +367.85% |
| Worst | +35.10% |
| % of Windows Positive | 100.0% |
Risk Metrics
| Maximum Drawdown | -79.83% |
| Average Drawdown | -39.71% |
| Drawdown Duration | 410 Trading Days |
| Sortino Ratio | 0.84 |
| Calmar Ratio | 0.14 |
| CVaR (5%) | -8.15% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +4.45% (+16.50% ann.) | +$444.53 | $0.00 | $0.00 | $0.00 |
| 2025 | +2.62% | +$262.42 | $0.00 | $0.00 | $0.00 |
| 2024 | -41.21% | $4120.58 | $0.00 | $0.00 | $0.00 |
| 2023 | +137.35% | +$13735.21 | $0.00 | $0.00 | $0.00 |
| 2022 | +108.33% | +$10833.35 | $0.00 | $0.00 | $0.00 |
| 2021 | -81.55% | $8155.45 | $0.00 | $0.00 | $0.00 |
| 2020 | +191.05% | +$19105.23 | $0.00 | $0.00 | $0.00 |
| 2019 partial | +59.50% (+141.94% ann.) | +$5949.75 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | June 21, 2019 – February 19, 2020 | +65.13% | +112.52% | +$6512.56 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -30.32% | -98.38% | $3031.64 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +331.24% | +950.22% | +$33123.90 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -84.69% | -83.15% | $8469.49 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +51.56% | +55.50% | +$5155.85 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +131.90% | +57.43% | +$13189.78 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | -8.13% | -5.26% | $813.15 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.